Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Sale |
2024-12-17 6:10 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
165 | $0.3523 | $58 | 22,563 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-17 6:08 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
3,117 | $0.36294 | $1,131 | 7,791,655 (Indirect Direct) |
View |
| 2024-12-16 Sale |
2024-12-17 6:06 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
577 | $0.35871 | $207 | 28,602 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-17 6:04 pm |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
430 | $0.35587 | $153 | 32,093 (Direct) |
View |
| 2024-12-16 Sale |
2024-12-17 6:03 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
430 | $0.35306 | $152 | 36,601 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-03 9:55 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
6,272 | $0.55 | $3,450 | 19,011 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-03 9:55 pm |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
6,863 | $0.55 | $3,775 | 23,770 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-03 9:54 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
7,175 | $0.55 | $3,946 | 28,278 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-03 9:54 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
7,175 | $0.55 | $3,946 | 20,279 (Direct) |
View |
| 2024-10-03 Sale |
2024-10-03 9:53 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
5,556 | $0.55 | $3,056 | 19,601 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:23 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
355 | $0.6893 | $245 | 22,955 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:21 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
1,982 | $0.68966 | $1,367 | 7,789,824 (Indirect Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:21 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
356 | $0.6899 | $246 | 14,956 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:20 pm |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
345 | $0.69 | $238 | 17,885 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:19 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
138 | $0.6908 | $95 | 7,034 (Direct) |
View |
| 2024-09-16 Sale |
2024-09-17 7:18 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
215 | $0.6908 | $149 | 11,533 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-07-22 Option Award |
2025-04-01 6:08 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
1,875 | $0 | 1,875 (Direct) |
View |
| 2024-07-22 Option Award |
2025-04-01 6:08 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
6,250 | $0 | 6,250 (Direct) |
View |
| 2024-07-22 Option Award |
2025-04-01 6:07 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
2,500 | $0 | 2,500 (Direct) |
View |
| 2024-07-22 Option Award |
2025-04-01 6:06 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. See Remarks |
1,875 | $0 | 1,875 (Direct) |
View |
| 2024-07-22 Option Award |
2025-04-01 6:04 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
2,500 | $0 | 2,500 (Direct) |
View |
| 2024-07-22 Option Award |
2025-04-01 6:02 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,875 | $0 | 1,875 (Direct) |
View |
| 2025-03-31 Exercise |
2025-04-01 6:02 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
1,693 | $0 | 20,317 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:38 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
65 | $0 | 1,989 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:37 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
65 | $0 | 2,207 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:36 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
65 | $0 | 2,489 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-17 6:35 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
379 | $0 | 488,122 (Direct) |
View |
| 2025-02-28 Exercise |
2025-03-04 9:21 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
1,693 | $0 | 20,317 (Direct) |
View |
| 2025-01-31 Exercise |
2025-02-04 5:28 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
27,089 | $0 | 325,077 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-16 08:04 am |
N/A 2035-01-15 |
BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director |
44,000 | $0 | 44,000 (Direct) |
View |
Ownership |
2025-01-16 08:03 am |
N/A 2033-12-08 |
BioXcel Therapeutics Inc. | BTAI | Patni Rajiv Director |
0 | $0 | 15,000 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 8:03 pm |
N/A 2035-01-07 |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
660,000 | $0 | 660,000 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 8:01 pm |
N/A 2035-01-07 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2025-01-07 Option Award |
2025-01-10 8:00 pm |
N/A 2035-01-07 |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 4:05 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
27,089 | $0 | 325,077 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:10 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
521 | $0 | 22,563 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:08 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
6,110 | $0 | 7,791,655 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:06 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,083 | $0 | 28,602 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:04 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
1,083 | $0 | 32,093 (Direct) |
View |
| 2024-12-14 Exercise |
2024-12-17 6:03 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,083 | $0 | 36,601 (Direct) |
View |
| 2024-11-30 Exercise(A) |
2024-12-04 4:05 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
27,089 | $0 | 325,077 (Direct) |
View |
| 2024-11-21 Option Award |
2024-12-03 4:05 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
297,988 | $0 | 325,087 (Direct) |
View |
| 2024-11-30 Exercise |
2024-12-03 4:05 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
27,089 | $0 | 325,087 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:06 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | MACK DAVID J. Director |
325,077 | $0 | 325,077 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:55 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
21,250 | $0 | 19,011 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:55 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
21,250 | $0 | 23,770 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:54 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
21,250 | $0 | 28,278 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:54 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
21,250 | $0 | 20,279 (Direct) |
View |
| 2024-09-17 Option Award |
2024-10-03 9:53 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
21,250 | $0 | 19,601 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:23 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,084 | $0 | 22,955 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:21 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
6,109 | $0 | 7,789,824 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:21 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,084 | $0 | 14,956 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:20 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
1,084 | $0 | 17,885 (Direct) |
View |
| 2024-09-14 Exercise |
2024-09-17 7:19 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
521 | $0 | 7,034 (Direct) |
View |
| 2024-09-15 Exercise |
2024-09-17 7:18 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
750 | $0 | 11,533 (Direct) |
View |
| 2024-06-15 Exercise(A) |
2024-09-17 7:17 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
750 | $0 | 8,250 (Direct) |
View |